NEW Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod

View wishlist

info@evidentic.com

+49 30 959 99 8831

View wishlist

Epoetin zeta

Therapeutic Epoetin Zeta from the biosimilar Silapo® commercial drug
  • Therapeutic drugs as aliquots
  • Multiple drug batches
  • Consumable, so no license needed
  • Prompt Delivery
  • Fraction of the original drug price

BATCH NUMBER: 0o013U0

0,08 €

/IU

In stock

Product specifications:​​

  • Quality Standard clinical-grade
  • Product Concentration 40000 IU/mL
  • Volume per vial 125 µL
  • Quantity per vial 5000 IU
  • Origin of the commercial drug DE
  • Batch Number 0o013U0
  • Storage Temperature -80°C
  • Original therapeutic expiry date: 2022.08

Our products are for research use only. The “therapeutic expiration date” implies expiry date for patient adminstration and is not applicable to the shelf life of the aliquot. Aliquot storage at -86°C ensures fully functional molecules even after the mentioned expiry date.

Product Information:

Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots or aRMP, or short: aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.

As ‘raw material’ for the production of drug aliquots, Evidentic sources RMP from the European (EU) market. As a licensed pharmaceutical wholesaler, Evidentic is committed to Good Distribution Practice (GDP) compliance with respect to the procurement, storage and shipment of RMP.

Drug aliquots are manufactured by repackaging RMP in a qualified laboratory. The aliquotation process is performed under a quality and manufacturing agreement between Evidentic and the contract manufacturer. Repackaging of RMP includes the following steps: opening the secondary and primary RMP containers and transferring the specified volumes of RMP into an Eppendorf 0.5 ml low-binding (or similar) tube. If the RMP is a lyophilized powder and not a highly concentrated solution, reconstitute the RMP according to the original manufacturer’s instructions and then aliquot as a highly concentrated solution.

For identification purposes, drug aliquots are labeled with the date of aliquoting, the original lot number of the RMP, the original expiration date of the RMP, the name of the active ingredient (INN), and a unique identification code.

Immediately after aliquoting, drug aliquots are stored at either 2-8 °C or -86 °C for long-term storage. All drug aliquots stored at 2-8 °C are transferred to -86 °C at least two weeks before the expiration date of the original RLD/RMP is reached.

Further quality or functional testing are not performed on the drug aliquots.

Target

Class of molecule

,

Isotype

Host cells

Chinese Hamster Ovary (CHO)

Prepared from (Reference drug)​

Silapo®

Therapeutic Area

Therapeutic Indications

Mechanism of Action (MoA)

EPO is involved in all phases of erythroid development, and has its principal effect at the level of erythroid precursors. After EPO binds to its cell surface receptor, it activates signal transduction pathways that interfere with apoptosis and stimulates erythroid cell proliferation.

Pharmacotherapeutic group​​

Other antianaemic preparations, erythropoietin

List of Excipients​

Disodium phosphate dihydrate Sodium dihydrogen phosphate dihydrate Sodium chloride Calcium chloride dihydrate Polysorbate 20 Glycine Leucine Isoleucine Threonine Glutamic acid Phenylalanine Water for injections Sodium hydroxide (pH adjuster) Hydrochloric acid (pH adjuster)

Batch specific analytical data available​

Evidentic’s analytical service includes a comprehensive array of methods to support the drug development process, including, for example, structure, aggregation, degree of isomerization and N-glycans identification of the active pharmaceutical ingredient (API). ​

Request an individual offer​

+ download a free sample​

1. Choose your(s) method(s) of interest
2. Provide your contact details
3. Send us your request and download a free sample report


Please provide your contact information


send us your inquiry and download a free sample file


How the ordering process works:

1 - Create your private shopping list by adding products of your interest.

2 – Export your private shopping list as a PDF to discuss internally.

3 – Send your shopping list with one click and receive a quote within 24 hours.

More Reference Drugs as Aliquots

Filters Sort results
Reset Apply
Product batch
Expiry date
Brand & Origin
Price
1. Select quantity range
2. Your quantity
Adalimumab 1120078A
2021.12
Amgevita®
DE
152,00 € /mg
Select quantity:
Max: 20
Min: 2
Step: 2
Max: 20
Min: 2
Step: 2
mg
Add to list
Adalimumab 1825216
2023.02
Hulio®
DE
152,00 € /mg
Select quantity:
Max: 20
Min: 2
Step: 2
Max: 20
Min: 2
Step: 2
mg
Add to list
Adalimumab 1909689A
2023.10
Hukyndra®
DE
152,00 € /mg
Select quantity:
Max: 20
Min: 2
Step: 2
Max: 20
Min: 2
Step: 2
mg
Add to list
Adalimumab 2LJP01T11
2024.02
Yuflyma®
DE
354,00 € /mg
Select quantity:
Max: 10
Min: 1
Step: 1
Max: 10
Min: 1
Step: 1
mg
Add to list
Adalimumab 2LJPO1T11
2024.02
Yuflyma®
DE
88,50 € /mg
Select quantity:
Max: 40
Min: 4
Step: 4
Max: 40
Min: 4
Step: 4
mg
Add to list
Adalimumab AU034994
2023.10
Idacio®
DE
177,50 € /mg
Select quantity:
Max: 20
Min: 2
Step: 2
Max: 20
Min: 2
Step: 2
mg
Add to list
Adalimumab GR226512
2023.10
Imraldi®
DE
152,00 € /mg
Select quantity:
Max: 20
Min: 2
Step: 2
Max: 20
Min: 2
Step: 2
mg
Add to list
Adalimumab MA8208
2024.06
Hyrimoz®
DE
152,00 € /mg
Select quantity:
Max: 20
Min: 2
Step: 2
Max: 20
Min: 2
Step: 2
mg
Add to list
Bevacizumab
Date to be defined
Abevmy®
DE
102,00 € /mg
Select quantity:
Max:
Min: 1
Step: 1
Max:
Min: 1
Step: 1
mg
Add to list
Bevacizumab
Date to be defined
Aybintio®
DE
102,00 € /mg
Select quantity:
Max:
Min: 20
Step: 2
Max:
Min: 20
Step: 2
mg
Add to list
Bevacizumab
Date to be defined
Vegzelma®
DE
102,00 € /mg
Select quantity:
Max:
Min: 1
Step: 1
Max:
Min: 1
Step: 1
mg
Add to list
Bevacizumab
Date to be defined
Aybintio®
102,00 € /mg
Select quantity:
Max:
Min: 11
Step: 1
Max:
Min: 11
Step: 1
mg
Add to list
Bevacizumab
Date to be defined
Abevmy®
107,00 € /mg
Select quantity:
Max:
Min: 11
Step: 1
Max:
Min: 11
Step: 1
mg
Add to list
Bevacizumab
Date to be defined
Vegzelma®
102,00 € /mg
Select quantity:
Max:
Min: 11
Step: 1
Max:
Min: 11
Step: 1
mg
Add to list
Eculizumab
Date to be defined
Epysqli®
DE
137,00 € /mg
Select quantity:
Max:
Min: 48
Step: 3
Max:
Min: 48
Step: 3
mg
Add to list
Eculizumab
Date to be defined
Epysqli®
DE
137,00 € /mg
Select quantity:
Max: 20
Min: 16
Step: 1
Max: 20
Min: 16
Step: 1
mg
Add to list
Etanercept 2110190088
2023.04
Erelzi®
DE
68,00 € /mg
Select quantity:
Max: 40
Min: 8
Step: 4
Max: 40
Min: 8
Step: 4
mg
Add to list
Etanercept GR206474
2023.11
Benepali®
DE
68,00 € /mg
Select quantity:
Max: 27
Min: 1
Step: 1
Max: 27
Min: 1
Step: 1
mg
Add to list
Etanercept Y10005702
2023.08
Nepexto®
DE
68,00 € /mg
Select quantity:
Max: 40
Min: 8
Step: 4
Max: 40
Min: 8
Step: 4
mg
Add to list
Infliximab
Date to be defined
Remsima®
DE
120,00 € /mg
Select quantity:
Max:
Min: 20
Step: 2
Max:
Min: 20
Step: 2
mg
Add to list
Infliximab EC1216
2025.01
Flixabi®
DE
119,50 € /mg
Select quantity:
Max: 20
Min: 4
Step: 2
Max: 20
Min: 4
Step: 2
mg
Add to list
Infliximab GF5988
2027.03
Inflectra®
90,00 €/mg
Max: 78
Min: 1
Step: 1
mg
Add to list
Infliximab SUR22
2022.10
Zessly®
DE
120,50 € /mg
Select quantity:
Max: 20
Min: 4
Step: 2
Max: 20
Min: 4
Step: 2
mg
Add to list
Ranibizumab
Date to be defined
Ranivisio®
621,00 € /mg
Select quantity:
Max: 10
Min: 5
Step: 1
Max: 10
Min: 5
Step: 1
mg
Add to list
Ranibizumab
Date to be defined
Ximluci®
680,00 € /mg
Select quantity:
Max: 10
Min: 5
Step: 1
Max: 10
Min: 5
Step: 1
mg
Add to list
Ranibizumab
Date to be defined
Byooviz®
621,00 € /mg
Select quantity:
Max: 10
Min: 5
Step: 1
Max: 10
Min: 5
Step: 1
mg
Add to list
Rituximab
Date to be defined
Truxima®
117,00 € /mg
Select quantity:
Max:
Min: 10
Step: 1
Max:
Min: 10
Step: 1
mg
Add to list
Rituximab LA1717
2025.12
Ruxience®
DE
76,00 €/mg
Max: 80
Min: 1
Step: 1
mg
Add to list
Rituximab LA1717
2025.12
Ruxience®
DE
202,00 € /mg
Select quantity:
Max: 40
Min: 1
Step: 1
Max: 40
Min: 1
Step: 1
mg
Add to list
Rituximab NB6052
2026.03
Rixathon®
DE
92,00 €/mg
Max: 74
Min: 1
Step: 1
mg
Add to list
Rituximab NB6052 test
Date to be defined
Max:
Min: 1
Step: 1
mg
Add to list
Trastuzumab
Date to be defined
Ontruzant®
DE
62,00 € /mg
Select quantity:
Max:
Min: 42,042
Step: 6
Max:
Min: 42,042
Step: 6
mg
Add to list
Trastuzumab
Date to be defined
Ontruzant®
62,00 € /mg
Select quantity:
Max:
Min: 15
Step: 1
Max:
Min: 15
Step: 1
mg
Add to list
Trastuzumab 1158597B
2025.01
Kanjinti®
DE
61,17 € /mg
Select quantity:
Max: 60
Min: 6
Step: 6
Max: 60
Min: 6
Step: 6
mg
Add to list
Trastuzumab 221204021
2026.08
Zercepac®
DE
52,00 €/mg
Max: 90
Min: 1
Step: 1
mg
Add to list
Trastuzumab BF21003653
2025.10
Ogivri®
DE
56,00 €/mg
Max: 72
Min: 1
Step: 1
mg
Add to list
Trastuzumab GR1676
2026.09
Trazimera®
DE
61,00 €/mg
Max: 110
Min: 1
Step: 1
mg
Add to list

Looking for a specific molecule?

Browse aliquots

Have a question?

Talk to us

Thank you for your interest in our services.

We will respond to you within one working day. You can now download your sample report.